A Study of Glaucoma or Ocular Hypertension in Patients Within the United States

Clinical trial NCT00800267 · COMPLETED

Trial details

NCT number: NCT00800267
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Hypertension Glaucoma

Start date: 1997-07-01
Primary completion: 1999-06-01
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.